EP Patent

EP4479059A4 — Specific N-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for the treatment of hidradenitis suppurativa

Assigned to Insmed Inc · Expires 2026-01-28 · 0y expired

What this patent protects

Patent listed against Brinsupri.

Drugs covered by this patent

Patent Metadata

Patent number
EP4479059A4
Jurisdiction
EP
Classification
—
Expires
2026-01-28
Drug substance claim
No
Drug product claim
No
Assignee
Insmed Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.